PTC Therapeutics PTCT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 1.6%-52.6pp | 54.2%+10.6pp | 43.6%+2.9pp | 40.7%+0.5pp | 40.2%+77.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×-0.5× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×+0.3× | |
| Liquidity | ||||||
| Current ratio | 2.4×+0.1× | 2.3×0.0× | 2.3×-1.3× | 3.6×-0.3× | 3.9×+1.5× | |
| Leverage | ||||||
| Net debt / EBITDA | -7.3×-6.7× | -0.6×-0.3× | -0.3×+0.5× | -0.8×+0.6× | -1.5×— | |
| Per Share | ||||||
| Book value per share | -$2.19+5.9% | -$2.32-30.0% | -$1.79+32.3% | -$2.64-22.9% | -$2.15+85.0% | |
| Valuation | ||||||
| Market capitalization | $5.64B-7.5% | $6.1B+25.1% | $4.88B+24.0% | $3.93B-2.2% | $4.02B+15.4% | |
| Price / sales | 6.8×+3.3× | 3.5×+0.8× | 2.7×+0.5× | 2.2×0.0× | 2.3×-2.0× | |
| EV / EBITDA | 86.6×+81.0× | 5.6×-0.1× | 5.7×+1.3× | 4.4×+0.5× | 4×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PTC Therapeutics's profit margins?
- PTC Therapeutics (PTCT) runs a 96.0% gross margin and a 1.6% operating margin, with a 42.3% net margin.
- Where do PTC Therapeutics's ratios come from?
- Every ratio is computed from PTC Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
